Influence of Humoral Response Against GnRH, Generated by Immunization with a Therapeutic Vaccine Candidate on the Evolution of Patients with Castration-Sensitive Prostate Adenocarcinoma

BACKGROUND AND AIMS: A gonadotropin-releasing hormone (GnRH)-based therapeutic vaccine candidate against hormone-sensitive prostate cancer has demonstrated its safety and signs of efficacy in phase I/II trials. In this study, we characterized the isotype/subclass profiles of the anti-GnRH humoral re...

Descripción completa

Detalles Bibliográficos
Autores principales: Campal-Espinosa, Ana Cristina, Junco-Barranco, Jesús Arturo, Fuentes-Aguilar, Franklin, Calzada-Aguilera, Lesvia, Rivacoba-Betancourt, Annia, Rodríguez-Bueno, Ranfis Humberto, Bover-Campal, Ana Claudia, Bover-Fuentes, Eddy Emilio, González, Lourdes, de Quesada, Lourdes, Alvarez, Allelin, Garay-Pérez, Hilda Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Vaccines for cancer immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576932/
https://www.ncbi.nlm.nih.gov/pubmed/37828833
http://dx.doi.org/10.1177/15330338231207318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576932/
https://www.ncbi.nlm.nih.gov/pubmed/37828833
http://dx.doi.org/10.1177/15330338231207318

Ejemplares similares